Tag Archive | "nifty"

Tags: , , , , , , , , , , , , , , , , , , , ,

NAC Global Technologies, Inc.

NAC Global Technologies, Inc., is an emerging growth, development and manufacturing company operating in the robotics, automation and defense industries.  NAC is making significant announcements in clean energy technology as well as in market validation and acceptance of its products.

Key Highlights:

·       Operational with Fortune 500 customers

·       Platform technology is harmonic gearing for precise motion control

·       Successful sales in Industrial, Communications, Medical, Robotics, and Defense Industries

·       Estimated addressable market is 500M with little competition

·       Emerging multi-billion dollar market applications in clean energy and medical

·       Expanding to meet existing demand

·       Strong management team

The company has its corporate headquarters in Jacksonville, FL and manufacturing, warehousing, and offices in Port Jervis, NY.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Grizzly Discoveries Inc – GZDIF

Grizzly trades on the TSX Venture Exchange under the symbol GZD, on the OTCQX exchange under the symbol GZDIF, and the Frankfurt Exchange under the symbol G6H, with 48,475,268 common shares issued and outstanding.

Grizzly is an aggressive and diversified Canadian mineral exploration company exploring for: potash in Alberta; world class gold and base metal deposits in British Columbia; and diamonds in Alberta. Grizzly holds, or has an interest in, metallic and industrial mineral permits for potash totaling more than 900,000 acres along the Alberta-Saskatchewan border. Grizzly currently has four precious-base metal properties in British Columbia totaling over 235,000 acres. Grizzly also currently holds more than 600,000 acres in diamond properties, which host diamondiferous kimberlites in the Buffalo Head Hills and Birch Mountains of Alberta.


• Canadian company focused on precious metals in BC and Potash in Alberta

• Extensive claim holdings in BC and Alberta

• Exploration results returned Gold, Silver, Copper, Platinum, Palladium, Lead, Zinc, Graphite, Potash and Diamonds

• Over 25% owned by Management

• Experienced Management with proven track record of success

• 225,000 acres at Greenwood, BC

• Numerous historic mines in the area

• Over 6 M oz gold produced in area

• Discovered 7 different mineralized areas within Greenwood property

• Ket 28 area diamond drill assays:

- 2.77 g/t Au over 11.0 m

- 11.9 g/t Au over 2.0 m

• Ket 28 area 7 km north of Kinross Buckhorn mine and mill

• Near surface high grade gold open pit potential

• Gold, Silver, Copper, Platinum, Palladium, Lead, Zinc, Graphite

• GZD has spent >$6 M to date

• French and Peak claims in northern BC contain Gold, Silver, Copper, Zinc

• Three diamondiferous kimberlites and four others discovered on Alberta diamond properties

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , ,



PuraMed BioScience®, Inc., is a pharmaceutical company specializing in the research, development, and marketing of safe, highly effective, non-prescription medicinal and healthcare products with the purpose of reaching and improving the quality of life for underserved populations in the OTC marketplace.

By applying hard science to natural products, PuraMed BioScience is committed to the establishment of a leadership position in the OTC natural and alternative health remedy market by introducing a safe and effective product line” that delivers better performance with fewer side effects than its chemical counterparts.

PuraMed BioScience recently formed a new division within the company to research, develop, and distribute a line of products incorporating hemp-derived cannabinoids as key components. The company plans to launch additional cannabinoid-enhanced, anti-inflammatory and anxiolytic products as it moves forward in the development of its CBD product line.

PuraMed BioScience, Inc., employs the use of double-blind placebo controlled testing to establish efficacy and safety benchmarks for products made with natural ingredients. Using this information, PuraMed BioScience directs marketing efforts directly to the consumer, retail, and product-related patient populations.

LipiGesic M, PuraMed’s flagship formulation, is a homeopathic medication using feverfew and ginger delivered sublingually (under the tongue) for the relief of migraine pain and associated symptoms. This initial product from the company has been clinically tested and featured in three (3) top-tier medical journals with articles authored by America’s leading migraine headache experts.

Based on the results of the clinical trials, LipiGesic M has an efficacy that is comparable to the top-selling triptan medication. However, LipiGesic M has an excellent safety profile, is non-drowsy and has no reported interactions with other medications. With this initial product, PuraMed BioScience has met the criteria the company set to create a superior natural product that works better than its chemical counterpart in the resolution of migraine pain and associated symptoms.

About the Company

PuraMed BioScience was established to capture two unique opportunities. The first is to build a substantial and profitable business with the distribution of LipiGesic® M a formulation created for the acute relief of migraine headaches. PuraMed BioScience is also reviewing several third-party health and wellness products that can be incorporated into the company’s product offering. Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer-term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative-health remedy market by introducing a “new kind of product line.” The PuraMed BioScience product line will consist of ‘alternative’ remedies for common ailments. With effective messaging campaigns, these products have the potential to be adopted by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

Company Management

Each member of the PuraMed BioScience management team brings decades of experience needed to compete in the over-the-counter and alternative health industry. This experience includes product development, drug formulation, direct marketing, sales, regulatory compliance and approval, and senior management of both public and private companies.

Business Strategy

PuraMed BioScience® Inc., intends to execute according to the following seven-step strategy.

1. Identify effective products with large market opportunities.

2. Employ a unique and effective delivery system.

3. Perform clinical trials and obtain clinical results to overcome consumer skepticism.

4. Employ a direct-response sales campaign to refine the consumer message and generate initial revenue.

5. Achieve broad, retail distribution to provide easy and widespread consumer access.

6. Apply effective marketing to drive consumer awareness and the buying impulse.

7. Capture “first-mover” advantage.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strategic Global Investments, Inc. – STBV

Strategic Global Investments provides live streaming video content and related digital advertising via its websites and social media. The company’s online business is divided into the two segments—WaZillo, and WaZilloMedia—as summarized on the right.

The convergence of a number of key social, technical, and economic factors are driving the market and making this the right time for Strategic’s online solutions.

Video: There is no question that online video continues to boom. According to Internet audience measurement firm comScore Media Metrix, video watching now accounts for approximately one-eighth of Americans’ total time spent on the Internet.

Broadband: A key driver for streaming video has been broadband access, which has been rapidly adopted over the past ten years. More than 85% of all Americans now use broadband access from their homes.

Mobile Connectivity: The growth in mobile media usage is largely attributable to the growth in smartphone adoption, 3G/4G device ownership and the increasing ubiquity of unlimited data plans, all of which facilitate the consumption of mobile media.

Search: Online it’s easy to find information. Major search engines are among the most heavily trafficked sites on the Web. People are increasingly turning to the Web—and not solely search engines—as their source of information for making decisions of all types.

Immediacy: Sparked by Facebook and Twitter, the real-time trend represents the growing demand for immediacy in people’s activities and interactions. Immediacy is compelling, engaging, and highly addictive—it’s a sense of living in the now.

Demographics: Adults in their twenties and thirties are the most socially active age group. They like to go out to meet new people, socialize with their friends, people watch, and dance. In the U.S. 27% of the population is between the ages of twenty and forty—82.9 million people in total.

The expectation of real-time, on demand information is becoming a part of every aspect of people’s lives. Strategic Global Investments is positioned to benefit as people’s focus and purchasing dollars continue to shift to online resources.

Company Website;


Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , ,

Radiant Creats Group INC – RCGP

The Radiant Creations Group (Radiant) (Trading Symbol-RCGP) develops and markets unique and proprietary cosmetic and over the counter products. These products use both new technologies and ingredients, such as herbal extracts from the centuries of proven Traditional Chinese Medicine. Dr. Yin-Xiong Li, M.D. Ph.D., world-renowned geneticist and a Chief Medical Officer in China, is the chief scientific advisor to Radiant, and has developed or enhanced most of the company’s products. Radiant acquired an exclusive license agreement for Dr. Li’s patented and trade secret technologies; a patent for “Enhanced Broad – Spectrum UV Radiation Filters and Methods” an improvement application for DNA protection from UV radiation, an anti-aging skin rejuvenation cream, an acne over-the-counter treatment, a wrinkle reduction cream, and nutritional supplements for BioSalt redistribution technology for liver health, hypertension, and weight control. The recent asset transaction included the transfer of the licensing agreement, inventory, and other related intellectual property from The Renewable Corporation.

The comprehensive asset acquisition includes innovative technologies in skin protection from the sun, industrial UV sources (such as welding), and reducing collateral damage from medical radiation treatment. The patented technology strips out the four nucleotide code molecules from DNA strands and uses them in a system that can provide up to 99% protection from DNA damage from high energy UV light, which is the major cause of aging and skin cancer.

The harmful effects of sunburn are well known, but exposure to the UV radiation in sunlight does more than just damage the surface of the skin. DNA damage, such as free radicals, oxidative stress, and mutational changes can lead to cancer and other serious conditions. Many sunscreen products currently in use do not provide sufficient protection; in fact, some contain ingredients that break down under UV radiation and form chemicals that actively damage the skin. With dangerous new levels of UV-B radiation now reaching the surface of the earth due to atmospheric damage, the risk of radiation exposure has increased exponentially. In addition, the technology can be used for increased protection in the workplace, in medical treatment radiation exposure to Beta and Gamma rays, and other opportunities in the industrial and architectural markets.

A second technology is the delivery system to house the nucleotides, and also a hydration agent that is time released to infuse uniform hydration in the skin for up to 10 hours. The enhanced skin hydration level “off loads” the skin’s repair mechanisms, freeing them to work on repairing other imperfections, resulting in significant anti-aging and rejuvenation benefits.

The resulting products from these two technologies are a nucleotide based SPF-30 sunblock; an anti-aging and rejuvenating cream featuring the hydration system, Chinese herbs, and aloe; a medical radiation protection and healing cream for use by dermatologists in radiation therapy for skin cancer, and a rejuvenating nucleotide protection cream for the tanning bed industry, for DNA damage protection. The asset acquisition allows Radiant to capitalize on multiple scientific breakthroughs with remarkable potential. These exciting discoveries for skin care are branded as the “Revivasol” skin care line.

A second product line is BioSalts, an innovative product line for the dietary supplement market. The BioSalts products have been formulated using an exclusive combination of natural Chinese herbal ingredients with advanced technologies utilizing molecular elements that help regulate energy homeostasis to promote various positive health benefits such as fat burning, weight loss, weight control, increased energy, enhanced sleep, tissue regeneration and lower blood pressure. The technology as a supplement also promotes liver health.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Lions Gate profit dives on debt extinguishment

Lions Gate Entertainment Corp.’s LGF -0.47% fiscal second-quarter profit declined 99% as the company logged an increase in charges for the early extinguishment of debt and as it faced a tough comparison from the year-earlier home entertainment release of “The Hunger Games.”

Lions Gate took on the big dogs in Hollywood last year with the first in the young-adult dystopia series “The Hunger Games” and the conclusion of the “Twilight” movies, which it acquired when it bought independent studio Summit Entertainment. The next installment of the “Hunger Games” franchise hits theaters in two weeks. Motion-picture revenue fell 29% to $434.4 million in the latest period.

The studio also produces popular TV programming. Revenue from television production fell 35% to $64.3 million as the timing of domestic television deliveries offset gains in international revenue driven by “Orange is the New Black” and “Anger Management.”

For the period ended Sept. 30, Lions Gate reported a profit of $505,000, or breakeven a share, compared with a year-earlier profit of $75.5 million, or 53 cents a share. The latest period included $36.2 million in debt extinguishment losses, compared with $1 million a year earlier. Excluding items such as stock-based compensation and losses on debt extinguishment, earnings were 18 cents a share compared with 58 cents a year earlier.

Revenue fell 29% to $498.7 million.

Analysts polled by Thomson Reuters were expecting a loss of eight cents a share and revenue of $529 million.

Home-entertainment revenue from both motion pictures and television was down 24% to $209.9 million.

Shares closed at $32.14 and were inactive premarket. The stock has nearly doubled since the start of the year.

Write to Nathalie Tadena at nathalie.tadena@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/lions-gate-profit-dives-on-debt-extinguishment-2013-11-08

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Readen Holding Corp – RHCO

Readen Holding Corp, a Venture Capital organisation,investor and shareholder of companies operating in hree separate industries. Readen Holding Corp. has access to an extensive, influential and loyal network of business relations and investors.

Readen Group’s mission statement is to be a valuable partner for customers in terms of technical flexibility, quality and competitive pricing through the complete value chain (SIM cards, mobile phones and applications).

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Advanced Defense Technologies, Inc. designs and develops high performance integrated circuits, modules, subsystems for military defense systems, homeland security, and wideband communications systems. The company offers multi-band phased array antennas, T/R modules, wideband transceivers, diplexer/multiplexer networks, electronically steered antennas, and wideband RF antenna systems covering the frequency range from UHF to 40 GHz for high data rate multi-point communications, mobile communications, and wideband tracking radar and sensor systems. In addition, Advanced Defense Technologies, Inc. specializes in solving unique problems through custom designs to meet the special requirements for sophisticated antenna systems.

Breakthroughs in Technology

The major technology breakthroughs resulting in the circuits and subsystems with increased bandwidth and efficiency have been accomplished under a number of Department of Defense Phase I and Phase II SBIR contracts including:

•Multi-band Phased Array Antenna Technology for Global Communication Systems, sponsored by USASMDC. Contract Number DASG60-03-C-0082.*

•Small size, multi-frequency and multi-beam phased array antenna, sponsored by USAF, Wright-Patterson Lab. OH USAF Contract: F33615 – 99 C -1406.*

•Multi-band Air Defense/Air Search Radar. Contract Number M67854-04-C-2003

•Microwave power transfer using microwave integrated circuit
technology, sponsored by NASA Johnson Space Center.*

•Alternate power sources for aerostats, sponsored by DARPA.*

•Quasi-optical power devices sponsored by the U.S. Army.*

•Space power and propulsion technology, sponsored by USAF, Phillips Lab.*

•Advanced rectenna technology for space power, sponsored by DARPA.*
* ADTI owns the technology developed under RST Scientific Research, Inc., which was the company under which these contracts were awarded.

Important Technological Developments

The major technology breakthroughs resulting in the circuits and subsystems with increased bandwidth and efficiency have been accomplished under a number of Department of Defense Phase I and Phase II SBIR contracts including:

1. Transceivers to transmit at 10, 19, and 32 GHz and receive at 12, 21, and 35 GHz

•The entire system is full-duplex so that the transmit and receive links operate simultaneously using the same antenna array.

•The system architecture developed allows the entire phased array to operate using a single low-loss broadband phase shifter.

2. Multi-band phased array radar prototype operating from 3 to 20 GHz.

•The new phased array technology provides significant reduction in DC power consumption, size, volume and cost. The technology enhances system efficiency, reliability and c ompactness.

•The technology was developed in collaboration with Texas A&M University and demon strates electronically beam scanned antenna arrays in 2-D planes at X-band (8 to 12 GHz) in AZ and EL planes, and beam scanning capability from 8 GHz to 35 GHz.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , ,



Headquartered in Sunnyvale, California, Mimvi, Inc. (MIMV) is a leading mobile search and discovery technology provider. Its proprietary search and “intelligent” recommendation algorithms enable the search and discovery of Mobile Apps, Mobile Content and Mobile Products across multiple devices and platforms, including: Apple’s iPhone and iPad, Google Android, BlackBerry, Windows Phone, Facebook and web applications. For more information, please visit: http://www.mimvi.com.

Capitalizing on the Mobile Market

This is an exciting time to be in the mobile business.
Mobile Apps have become the new “websites” and Mimvi enables the discovery of the most relevant Mobile Apps, Mobile Content and Mobile Products through a single unified search interface. As a search engine technology company, Mimvi is perfectly positioned to capitalize on the unprecedented growth and fragmentation that exists in the mobile industry. This growth strategy includes targeting key markets, including China.

With the current count of almost 1,500,000 Mobile Apps available to consumers, and growth at never-before-seen levels, Mimvi provides investors the only publicly traded search engine for all Mobile Apps, Mobile Content and Mobile Products, regardless of platform, device or content.

Spotlight CEO, Michael Poutre

Mike is a 20 year veteran of the securities industry. His experience ranges from working at some of the largest wire house firms in the world, to having owned his own broker-dealer. Mike has many years of experience in the capital markets as a portfolio manager, and has been cited or featured in numerous premier financial publications, including Forbes, Business Week, The New York Times and The Los Angeles Times.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Yum Brands profit falls 5% as China sales slump

Yum Brands Inc.’s YUM -5.54% fourth-quarter earnings slipped 5.3% as the fast-food chain’s same-store sales in China were hurt by negative publicity from a government review of poultry supplies there, though same-store sales in its U.S. business improved.

Shares slipped 4.6% to $61 after-hours Monday as the company said it no longer expects earnings-per-share growth this year due to continued negative same-store sales and its expectation that it will take time to recover consumer confidence.

The company now expects a midsingle-digit earnings-per-share decline in 2013. Yum projects a significant EPS decline in the first half of the year, followed by EPS growth in the latter half. Its November view called for per-share earnings growth of 10%, which was short of analyst estimates at the time.

The parent company of Taco Bell, KFC and Pizza Hut has seen its struggling domestic business show signs of a comeback recently, with same-store sales recently rising thanks in part to the successful launch of its Doritos Locos Tacos at Taco Bell.

In the latest quarter, U.S. same-store sales rose 3%, building on improvement in the previous four quarters, though operating earnings slipped 5.8%.

Yum’s China business, which is comprised primarily of KFC and Pizza Hut Casual Dining, has been crucial for the company’s growth, often contributing half of its total profits. However, same-store sales in China have softened in recent quarters as the country has shown signs of an economic slowdown. Rising food costs and wage inflation also have squeezed Yum’s profit margins in the country.

Same-store sales in China declined 6%, as poor publicity from a government review of China poultry supplies badly impacted its KFC operations there during the last two weeks of December. The China segment’s operating profit slipped 5% prior to currency changes.

The company said it is difficult to confidently forecast its overall financial performance given uncertainties related to KFC sales in China, but the company expects KFC China same-store sales to improve as the year progresses and to be positive in the fourth quarter.

“Although we cannot predict how long it will take to restore sales, we are steadfast in our belief that the power and popularity of the KFC brand in China will ultimately drive a full sales recovery,” said Chairman and Chief Executive David C. Novak.

Overall, Yum reported a profit of $337 million, or 72 cents a share, down from $356 million, or 75 cents a share, a year earlier. Excluding special items, earnings were 82 cents a share in the latest period. Revenue rose 1% to $4.15 billion.

Analysts polled by Thomson Reuters most recently projected earnings of 82 cents a share and revenue of $4.12 billion.

World-wide restaurant margin improved 0.1 percentage point to 14.4% for the quarter.

Through Monday’s close, the stock has fallen 11% over the past three months.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/yum-brands-profit-falls-5-as-china-sales-slump-2013-02-04

Posted in Featured, Stock NewsComments Off

Advertise Here